Your browser doesn't support javascript.
loading
Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein corona.
Wu, Jun-Yong; Li, Yong-Jiang; Wang, Jiemin; Hu, Xiong-Bin; Huang, Si; Luo, Shilin; Xiang, Da-Xiong.
Afiliação
  • Wu JY; Department of Pharmacy, The Second Xiangya Hospital of Central South University, 139 Middle Renmin Road, Changsha, 410011, China.
  • Li YJ; Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, China.
  • Wang J; Institute of Clinical Pharmacy, Central South University, Changsha, China.
  • Hu XB; Department of Pharmacy, The Second Xiangya Hospital of Central South University, 139 Middle Renmin Road, Changsha, 410011, China.
  • Huang S; Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, China.
  • Luo S; Institute of Clinical Pharmacy, Central South University, Changsha, China.
  • Xiang DX; Regenerative Medicine Institute (REMEDI), School of Medicine, College of Medicine, Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.
J Nanobiotechnology ; 19(1): 405, 2021 Dec 06.
Article em En | MEDLINE | ID: mdl-34872569
Targeted drug delivery to the glioblastoma (GBM) overcoming blood-brain barrier (BBB) has been challenging. Exosomes are promising vehicles for brain tumor drug delivery, but the production and purification hinder its application for nanomedicine. Besides, the formation of protein corona (PC) may affect the behaviour of nanocarriers. Here, multifunctional exosomes-mimetics (EM) are developed and decorated with angiopep-2 (Ang) for enhancing GBM drug delivery by manipulating PC. Docetaxel (DTX)-loaded EM with Ang modification (DTX@Ang-EM) show less absorption of serum proteins and phagocytosis by macrophages. Ang-EM show enhanced BBB penetration ability and targeting ability to the GBM. Ang-EM-mediated delivery increase the concentration of DTX in the tumor area. The multifunctional DTX@Ang-EM exhibits significant inhibition effects on orthotopic GBM growth with reduced side effects of the chemotherapeutic. Findings from this study indicate that the developed DTX@Ang-EM provide a new strategy for targeted brain drug delivery and GBM therapy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Exossomos / Coroa de Proteína / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Exossomos / Coroa de Proteína / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China